All In Biotech

Free tool

Medicare drug spending

CMS's Spending by Drug data: what Medicare paid for each drug before manufacturer rebates. Part D covers drugs dispensed by pharmacies; Part B covers drugs given in a doctor's office or hospital outpatient department. Commercial and list prices are not public data and are not shown.

Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations

Part D, 2024

$288.7B

Gross drug spending in the dataset

Part B, 2024

$60.8B

Gross drug spending in the dataset

Drugs listed

6

Part D and Part B

Total spending by year

  • Part D
  • Part B
View as table
YearPart DPart B
2020$194,092,038,339$37,778,829,680
2021$213,513,349,361$40,135,340,775
2022$239,779,215,689$44,241,259,745
2023$275,808,918,753$50,775,853,083
2024$288,667,842,058$60,838,164,403
Reset

Top 6 by total spending

2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.

DrugPartSpendingChangeBeneficiariesPer beneficiaryPer unit
Morphine Sulfate ER

Morphine Sulfate

D$58.2M-12%247,767$235$0.51
Morphine Sulfate*

Morphine Sulfate

D$17.1M-8%240,437$71$0.39
Duramorph*

Morphine Sulfate/PF* · J2274

B$1.6M-25%1,157$1,408$11.01
Ms Contin

Morphine Sulfate

D$716K-34%224$3,197$8.01
Morphine Sulfate (J2272)

Morphine Sulfate · J2272

B$355K+24951%34,313$10$7.23
Morphine Sulfate (J2270)*

Morphine Sulfate* · J2270

B$40K-13%2,893$14$4.37

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.